Unicycive Therapeutics, Inc.
UNCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,729 | -$30,544 | -$18,058 | -$10,017 |
| Dep. & Amort. | $428 | $284 | $161 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,350 | $1,767 | $1,047 | $966 |
| Change in WC | -$427 | -$93 | $1,178 | -$105 |
| Other Non-Cash | $5,803 | $10,303 | $21 | $3,376 |
| Operating Cash Flow | -$28,575 | -$18,283 | -$15,651 | -$5,767 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$72 | -$12 | -$2 | -$29 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$72 | -$12 | -$2 | -$29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$15 |
| Stock Issued | $683 | $0 | $11 | $22,271 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,095 | $0 | $0 | $0 |
| Other Fin. Act. | $45,500 | $27,541 | -$482 | $119 |
| Financing Cash Flow | $45,088 | $27,541 | -$471 | $22,375 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $16,441 | $9,246 | -$16,124 | $16,579 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,701 | $455 | $16,579 | $0 |
| End Cash | $26,142 | $9,701 | $455 | $16,579 |
| Free Cash Flow | -$28,647 | -$18,295 | -$15,653 | -$5,796 |